AstraZeneca scores patent victory

Drugs giant AstraZeneca was today celebrating its latest victory in the battle to protect its most valuable medicines from cheaper, unauthorised copies.

The company sued two firms for trying to market generic versions of Seroquel, a treatment for schizophrenia and bipolar depression.